Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85 CHF | +0.56% | -1.44% | -0.01% |
12:33am | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 18 | NOVARTIS AG : UBS reiterates its Buy rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.01% | 203B | |
+27.44% | 672B | |
+24.62% | 550B | |
-6.97% | 351B | |
+15.10% | 317B | |
+6.42% | 292B | |
+2.83% | 211B | |
-11.72% | 144B | |
-8.44% | 141B | |
-3.68% | 113B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis : Morgan Stanley Lowers Price Target on Novartis, Maintains Overweight/In-Line Recommendation